Lymphoma, Large-Cell, Anaplastic
Showing 9976 - 10000 of >10,000
Biomechanical Parameters of Human Movement Based on Disability
Recruiting
- Disability
- Exposure to disability
-
Porto, PortugalCenter for Rehabilitation Research, School of Health, Polytechni
Dec 12, 2022
HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple
Recruiting
- HER2-negative Early Breast Cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
- neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
-
Beijing, ChinaPeking University People's Hospital
Mar 27, 2022
Progression of Spinal Fusion in Ankylosing Spondylitis
Completed
- Ankylosing Spondylitis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Elaboration ofPrioritization Score for Pharmaceutical Interviews
Completed
- Thromboembolic Event
- Survey
-
Reims, FranceChu Reims
Oct 19, 2023
Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)
Active, not recruiting
- Non Small Cell Lung Cancer
- Necitumumab
- +2 more
-
Chandler, Arizona
- +181 more
Feb 4, 2022
Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic
Recruiting
- Oral Mucositis (Ulcerative)
- +3 more
- Photobiomodulation
- Routine Oral Care and Analgesia
-
Birmingham, Alabama
- +6 more
Jan 18, 2022
Total Knee Replacement Trial in Aarhus, Horsens, Silkeborg (Low-load blood flow restricted exercise)
Recruiting
- Total Knee Replacement
- Low-load blood flow restricted exercise
-
Aarhus, Aarhus N, Denmark
- +2 more
Dec 14, 2022
NSCLC Trial in Qingdao (Osimertinib Oral Tablet)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Osimertinib Oral Tablet
-
Qingdao, Shandong, ChinaQingdao Central Hospital, Qingdao Cancer Hospital
Nov 1, 2021
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Achilles Tendon Thickness, Plantar Fascia Thickness, Spatio-temporal Parameteres of Gait Trial
Not yet recruiting
- Achilles Tendon Thickness
- +2 more
- (no location specified)
Jul 27, 2023
First Line Recurrent/Metastatic Squamous Cell Carcinoma of Head
Completed
- Squamous Cell Carcinoma of the Head and Neck
-
Parsippany, New JerseyMedical Data Analytics
Nov 15, 2021
the Type ONe dIabetic Bone Collaboration Study
Recruiting
- Osteoporosis Secondary
- Diabetes Mellitus, Type 1
-
Aalborg, DenmarkSteno Diabetes Center Nordjylland
Dec 30, 2022
Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CAR-T Autologous T cell injection
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Dec 2, 2022
Relapsed/Refractory Small Cell Lung Cancer Trial in Worldwide (Tarlatamab)
Recruiting
- Relapsed/Refractory Small Cell Lung Cancer
-
Birmingham, Alabama
- +78 more
Jan 18, 2023
Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)
Clear Cell Tumor, Gynecologic Cancer, Advanced Cancer Trial in United Kingdom (Pembrolizumab)
Active, not recruiting
- Clear Cell Tumor
- +2 more
-
Edinburgh, United Kingdom
- +4 more
Oct 22, 2021
Celiac Disease Trial in Boston (Gluten Powder)
Recruiting
- Celiac Disease
- Gluten Powder
-
Boston, MassachusettsCeliac Research Centre Mass General Hospital
Jul 1, 2022
Non-Hodgkin Lymphoma Trial in Haikou (CD19-TriCAR-T/SILK)
Unknown status
- Non-Hodgkin Lymphoma
- CD19-TriCAR-T/SILK
-
Haikou, Hainan, China
- +2 more
Mar 11, 2020
Carcinoma,Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell, Non-small-cell Lung Carcinoma Trial in Worldwide (Pemetrexed,
Active, not recruiting
- Carcinoma,Non-Small-Cell Lung
- +3 more
- Pemetrexed
- +5 more
-
Albury, New South Wales, Australia
- +192 more
Sep 19, 2022
Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan
Active, not recruiting
- Myeloid Malignancies
- +4 more
- Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
- Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Feb 25, 2022
Missing Teeth Trial in Giza (mini-screw implant, removable partial denture)
Not yet recruiting
- Missing Teeth
- mini-screw implant
- removable partial denture
-
Giza, Al Manial, EgyptFaculty of Dentistry, Cairo University
Oct 16, 2023
COVID, SARS-CoV 2, Corona Virus Infection Trial in Antwerp
Recruiting
- COVID
- +4 more
-
Antwerp, BelgiumUniversitairy hospital of Antwerp
Apr 4, 2022